Minerva Neurosciences, Inc. (NERV)
2.47
-0.16
(-6.08%)
USD |
NASDAQ |
Nov 10, 16:00
2.47
0.00 (0.00%)
After-Hours: 20:00
Minerva Neurosciences Cash from Operations (Annual) : -13.51M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -13.51M |
| December 31, 2024 | -19.55M |
| December 31, 2023 | -14.78M |
| December 31, 2022 | -24.65M |
| December 31, 2021 | -24.60M |
| December 31, 2020 | -33.82M |
| December 31, 2019 | -43.43M |
| December 31, 2018 | -41.94M |
| Date | Value |
|---|---|
| December 31, 2017 | 3.093M |
| December 31, 2016 | -25.69M |
| December 31, 2015 | -24.27M |
| December 31, 2014 | -35.96M |
| December 31, 2013 | -2.160M |
| December 31, 2012 | -0.9085M |
| December 31, 2011 | -1.121M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Heron Therapeutics, Inc. | -27.59M |
| Tonix Pharmaceuticals Holding Corp. | -99.84M |
| Karyopharm Therapeutics, Inc. | -75.37M |
| Corbus Pharmaceuticals Holdings, Inc. | -64.49M |
| Ocugen, Inc. | -56.96M |